[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368402-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368402-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","long-term-use-of-low-dose-aspirin-for-cancer-prevention-a-20-year-longitudinal-cohort-study-of-1506525-hong-kong-residents-abstract","Long-term use of low-dose aspirin for cancer prevention - A 20-year longitudinal cohort study of 1,506,525 Hong Kong residents - Abstract","","Long-term use of low-dose aspirin has been shown to reduce cancer risk, yet the required duration of medication remains uncertain. This population-based study analyzed all aspirin users from 2000 to 2019 and compared them with age- and sex-matched non-users in a 1:2 ratio. Cancer incidence and mortality were assessed using Fine–Gray competing-risk survival models. Among 538,147 users, prolonged use over 10 years showed stronger chemoprotective effects for lung, breast, and colorectal cancers, with benefits also seen for early cancers starting at age 40.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/long-term-use-of-low-dose-aspirin-for-cancer-prevention-a-20-year-longitudinal-cohort-study-of-1506525-hong-kong-residents-abstract/368402/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/long-term-use-of-low-dose-aspirin-for-cancer-prevention-a-20-year-longitudinal-cohort-study-of-1506525-hong-kong-residents-abstract/368402.png","ImageObject",300,407,{"name":42,"@type":43},"Rhys","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of the study on low-dose aspirin and cancer prevention?","Question",{"text":63,"@type":64},"To investigate the long-term chemoprotective effect of aspirin in a Chinese population and determine how cancer risk changes with duration of use.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were outcomes such as cancer incidence and mortality analyzed?",{"text":68,"@type":64},"Cancer incidence and mortality were analyzed using survival methods with Fine–Gray modeling to account for competing risks.",{"name":70,"@type":61,"acceptedAnswer":71},"What did longer-term aspirin use show regarding cancer risk?",{"text":72,"@type":64},"Use for more than 10 years was associated with reduced risks of lung, breast, and colorectal cancers, and the protective association was also observed for early cancers starting as early as age 40.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368402,1790927794,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","DOI: 10.1002/ijc.35331  \nRES EARCH A RTICLE  \nCa ncer Epidemiology  \nLong-term use of low-dose aspirin for cancer prevention: A 20-year longitudinal cohort study of 1,506,525  \nHong Kong residents  \nAmy Lam 1  | Ziyu Hao 1 | Karen Yiu 2 | Stephen Chan 3 | Francis Chan 4 | Joseph Sung 5 | Kelvin Tsoi 1,2   \n1Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR  \n2Stanley Ho Big Data Decision Analytics Research Centre, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR 3State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Sir YK Pao Centre for Cancer, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR 4Department of Medicines and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR 5Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore  \nCorrespondence  \nJoseph Sung, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.  \nEmail: [josephsung@ntu.edu.sg](josephsung@ntu.edu.sg)  \nKelvin Tsoi, Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.  \nEmail: [kelvintsoi@cuhk.edu.hk](kelvintsoi@cuhk.edu.hk)  \nFunding information  \nHealth and Medical Research Fund, Grant/Award Number: CFS-CUHK1  \nAbstract  \nLong-term use of low-dose aspirin has been demonstrated to reduce cancer risk, but the duration of necessary medication use remains uncertain. This study aimed to investigate the long-term chemoprotective effect of aspirin among the Chinese population. This population-based study included all aspirin users between 2000 and 2019. Aspirin users were age-sex matched with non-users at a 1:2 ratio. Cancer incidence and mortality were the main outcomes measured. Survival analyses with the Fine–Gray modelling were performed. The chemoprotective effects were measured by the sub-distribution hazard ratios (SHR) with control for the competing risks. A total of 538,147 aspirin users and 968,378 non-users were included, with a mean age of 64.8 years, 9,543,399 person-years of follow-up and 90% of users with 80 mg aspirin. The long-term use of aspirin was associated with a reduced risk of cancer (SHR 0.92, 95% CI 0.91–0.94) and a reduced risk of cancer mortality (SHR 0.80, 95% CI 0 .79–0.82) . Stronger chemopreventive effects were observed among those who used aspirin for more than 10 years, including risk reductions for lung (SHR 0.56, 95% CI 0.51–0.60), breast (SHR 0.34, 95% CI 0.29–0.38) and colorectal (SHR 0.37, 95% CI 0 .33–0.40) cancers, but not for bladder cancer and leukaemia. Low-dose use of aspirin was associated with lower risk of cancer among Chinese. The association was even stronger for those using aspirin for more than 10 years. Prescription of aspirin may be started as early as at age of 40, as the chemoprotective effect also applied for early cancers.  \nKEYWOR DS  \naspirin, cancer, cancer prevention  \nWhat's New?  \nLow-dose aspirin use over an extended period is associated with a reduced risk of colorectal cancer (CRC) and potentially other malignancies. Duration of use to derive such benefits,  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2025 The Author(s) . International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.  \nhowever, remains unclear. This retrospective study examined low-dose aspirin use for possible chemoprotective effects among individuals in Hong Kong. Analyses show a link between longterm aspirin use and decreased risk of common cancers, including CRC, liver cancer and breast cancer. The association i","cbCaiqQ1ikVaPOQm","https://ap.wps.com/l/cbCaiqQ1ikVaPOQm","pdf",709660,"English","# Abstract\n# What's New?\n# Introduction","[{\"question\":\"What is the main objective of the study on low-dose aspirin and cancer prevention?\",\"answer\":\"To investigate the long-term chemoprotective effect of aspirin in a Chinese population and determine how cancer risk changes with duration of use.\"},{\"question\":\"How were outcomes such as cancer incidence and mortality analyzed?\",\"answer\":\"Cancer incidence and mortality were analyzed using survival methods with Fine–Gray modeling to account for competing risks.\"},{\"question\":\"What did longer-term aspirin use show regarding cancer risk?\",\"answer\":\"Use for more than 10 years was associated with reduced risks of lung, breast, and colorectal cancers, and the protective association was also observed for early cancers starting as early as age 40.\"}]","Long-term use of low-dose aspirin for cancer prevention - A 20-year longitudinal cohort study of 1,506,525 Hong Kong residents - Abstract | PDF",1790176765,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e9204e0bee44019f9c01a0798a1ebf7.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d8f84aa1956b3191cd0300485255b24.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02d3d6fecff5308139ba172b7098abc4.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/847f55c75bed188c9bf513d2a11144f6.webp",980,1287]